NIGELLA SATIVA APPLICATIONS IN ALLERGIC DISEASE CONTROL: NARRATIVE REVIEW

Authors

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.6633

Keywords:

Nigella Sativa, Thymoquinone, Rhinitis, Allergic, Asthma, Dermatitis, Atopic Immunomodulation

Abstract

Introduction and purpose: Allergic diseases are an increasing global health problem. As standard therapies may have limited efficacy or adverse effects, interest in natural adjuncts such as Nigella sativa and its main bioactive compound, thymoquinone, has grown. This narrative review summarizes evidence from 2017-2026 on N. sativa in allergy control, focusing on clinically relevant mechanisms and therapeutic applications.

State of knowledge: N. sativa exerts broad anti-allergic effects through immunomodulatory and anti-inflammatory pathways. Mechanisms include mast cell stabilization, reduced eosinophilic inflammation, IgE downregulation, Th1/Th2 balance modulation, and inhibition of inflammatory signaling pathways. Clinical studies suggest benefits in allergic rhinitis with reduced symptom severity and frequency, and in asthma with improved symptom control and pulmonary function. Promising findings exist for atopic dermatitis, mainly in preclinical models. Safety data are generally favorable, though outcomes depend on formulation, dose, and duration.

Summary: Nigella sativa appears promising as an adjunct in allergic disease management, not a substitute for standard pharmacotherapy. Its value is supported by multi-target immunomodulatory activity and good tolerability. However, evidence is limited by heterogeneous preparations, small populations, and short follow-up. Further well-designed randomized controlled trials are needed to establish optimal dosing, standardization, and long-term efficacy.

References

Bival Štefan M. (2024). Astragalus membranaceus, Nigella sativa, and Perilla frutescens as Immunomodulators-Molecular Mechanisms and Clinical Effectiveness in Allergic Diseases. Current issues in molecular biology, 46(8), 9016–9032. https://doi.org/10.3390/cimb46080533

Aslam, H., Shahzad, M., Shabbir, A., & Irshad, S. (2018). Immunomodulatory effect of thymoquinone on atopic dermatitis. Molecular immunology, 101, 276–283. https://doi.org/10.1016/j.molimm.2018.07.013

Al-Qubaisi, M. S., Rasedee, A., Flaifel, M. H., Eid, E. E. M., Hussein-Al-Ali, S., Alhassan, F. H., Salih, A. M., Hussein, M. Z., Zainal, Z., Sani, D., Aljumaily, A. H., & Saeed, M. I. (2019). Characterization of thymoquinone/hydroxypropyl-β-cyclodextrin inclusion complex: Application to anti-allergy properties. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 133, 167–182. https://doi.org/10.1016/j.ejps.2019.03.015

Koshak, A., Koshak, E., & Heinrich, M. (2017). Medicinal benefits of Nigella sativa in bronchial asthma: A literature review. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 25(8), 1130–1136. https://doi.org/10.1016/j.jsps.2017.07.002

Koshak, A. E., Yousif, N. M., Fiebich, B. L., Koshak, E. A., & Heinrich, M. (2018). Comparative Immunomodulatory Activity of Nigella sativa L. Preparations on Proinflammatory Mediators: A Focus on Asthma. Frontiers in pharmacology, 9, 1075. https://doi.org/10.3389/fphar.2018.01075

Majeed, A., Majeed, S., Parameswarappa, A. K., Murali, A., Gudimallam, S., Siddegowda, C., Chandrashekar, H., & Mundkur, L. (2024). A randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized Nigella sativa oil containing 5% thymoquinone in reducing the symptoms of seasonal allergy. Medicine, 103(32), e39243. https://doi.org/10.1097/MD.0000000000039243

Talebi, M., Talebi, M., Farkhondeh, T., & Samarghandian, S. (2021). Biological and therapeutic activities of thymoquinone: Focus on the Nrf2 signaling pathway. Phytotherapy research : PTR, 35(4), 1739–1753. https://doi.org/10.1002/ptr.6905

Orczyk, J., Ołownia, A., Tokarzewska, A., & Piecewicz-Szczęsna, H. (2023). Nigella Sativa - an ordinary herb or a miraculous medicine?. Journal of Education, Health and Sport, 13(5), 11–17. https://doi.org/10.12775/JEHS.2023.13.05.001

Negi, P., Rathore, C., Sharma, G., Singh, B., & Katare, O. P. (2018). Thymoquinone a Potential Therapeutic Molecule from the Plant Nigella sativa: Role of Colloidal Carriers in its Effective Delivery. Recent patents on drug delivery & formulation, 12(1), 3–22. https://doi.org/10.2174/1872211311666171129121128

Nasiri, N., Ilaghi Nezhad, M., Sharififar, F., Khazaneha, M., Najafzadeh, M. J., & Mohamadi, N. (2022). The Therapeutic Effects of Nigella sativa on Skin Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based complementary and alternative medicine : eCAM, 2022, 7993579. https://doi.org/10.1155/2022/7993579

Saadat, S., Aslani, M. R., Ghorani, V., Keyhanmanesh, R., & Boskabady, M. H. (2021). The effects of Nigella sativa on respiratory, allergic and immunologic disorders, evidence from experimental and clinical studies, a comprehensive and updated review. Phytotherapy research : PTR, 35(6), 2968–2996. https://doi.org/10.1002/ptr.7003

Kilinc, E., Dagistan, Y., Kotan, B., & Cetinkaya, A. (2017). Effects of Nigella sativa seeds and certain species of fungi extracts on number and activation of dural mast cells in rats. Physiology international, 104(1), 15–24. https://doi.org/10.1556/2060.104.2017.1.8

Dera, A., Rajagopalan, P., Ahmed, I., Alfhili, M., Alsughayyir, J., & Chandramoorthy, H. C. (2020). Thymoquinone attenuates IgE-mediated allergic response via pi3k-Akt-NFκB pathway and upregulation of the Nrf2-HO1 axis. Journal of Food Biochemistry, 44(6), e13216. https://doi.org/10.1111/jfbc.13216

Gul, R., Tansuker, H. D., Cengiz, A. B., Gul, M., Tabaru, A., Emre, F., & Oktay, M. F. (2022). Effects of nigella sativa oil on allergic rhinitis: an experimental animal study. Brazilian journal of otorhinolaryngology, 88 Suppl 5(Suppl 5), S148–S155. https://doi.org/10.1016/j.bjorl.2022.09.003

Liao, C., Han, Y., Chen, Z., & Baigude, H. (2021). The extract of black cumin, licorice, anise, and black tea alleviates OVA-induced allergic rhinitis in mouse via balancing activity of helper T cells in lung. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 17(1), 87. https://doi.org/10.1186/s13223-021-00587-6

Salem, A. M., Bamosa, A. O., Qutub, H. O., Gupta, R. K., Badar, A., Elnour, A., & Afzal, M. N. (2017). Effect of Nigella sativa supplementation on lung function and inflammatory mediatorsin partly controlled asthma: a randomized controlled trial. Annals of Saudi medicine, 37(1), 64–71. https://doi.org/10.5144/0256-4947.2017.64

Ulfa, L., Munir, D., Rambe, A. Y., Farhat, F., Wardani, R. S., Amin, M. M., Zahara, D., & Ardinata, D. (2025). Therapeutic potential of thymoquinone in regulating p63, claudin, and periostin in chronic rhinosinusitis with nasal polyps: An animal model study. Narra J, 5(1), e1728. https://doi.org/10.52225/narra.v5i1.1728

He, Y., Hu, X., Chang, L., Liu, S., Lv, L., Qin, G., & Jiang, L. (2024). Meta-analysis of randomized controlled trials assessing the efficacy of nigella sativa supplementation for allergic rhinitis treatment. Frontiers in pharmacology, 15, 1417013. https://doi.org/10.3389/fphar.2024.1417013

He, T., & Xu, X. (2020). The influence of Nigella sativa for asthma control: A meta-analysis. The American journal of emergency medicine, 38(3), 589–593. https://doi.org/10.1016/j.ajem.2019.11.036

Koshak, A., Wei, L., Koshak, E., Wali, S., Alamoudi, O., Demerdash, A., Qutub, M., Pushparaj, P. N., & Heinrich, M. (2017). Nigella sativa Supplementation Improves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial. Phytotherapy research : PTR, 31(3), 403–409. https://doi.org/10.1002/ptr.5761

Thomas, J. V., Mohan, M. E., Prabhakaran, P., Das S, S., Maliakel, B., & I M, K. (2022). A phase I clinical trial to evaluate the safety of thymoquinone-rich black cumin oil (BlaQmax®) on healthy subjects: Randomized, double-blinded, placebo-controlled prospective study. Toxicology reports, 9, 999–1007. https://doi.org/10.1016/j.toxrep.2022.04.020

Mashayekhi-Sardoo, H., Rezaee, R., & Karimi, G. (2020). An overview of in vivo toxicological profile of thymoquinone. Toxin Reviews, 39(2), 115–122. https://doi.org/10.1080/15569543.2018.1514637

Mashayekhi-Sardoo, H., Rezaee, R., & Karimi, G. (2020). Nigella sativa (black seed) safety: an overview. Asian biomedicine : research, reviews and news, 14(4), 127–137. https://doi.org/10.1515/abm-2020-0020

Razmpoosh, E., Safi, S., Abdollahi, N., Nadjarzadeh, A., Nazari, M., Fallahzadeh, H., Mazaheri, M., & Salehi-Abargouei, A. (2020). The effect of Nigella sativa on the measures of liver and kidney parameters: A systematic review and meta-analysis of randomized-controlled trials. Pharmacological research, 156, 104767. https://doi.org/10.1016/j.phrs.2020.104767

Wahab, S., & Alsayari, A. (2023). Potential Pharmacological Applications of Nigella Seeds with a Focus on Nigella sativa and Its Constituents against Chronic Inflammatory Diseases: Progress and Future Opportunities. Plants (Basel, Switzerland), 12(22), 3829. https://doi.org/10.3390/plants12223829

Ghobadi, H., Mohammadzadeh, E., & Aslani, M. R. (2025). Effects of Nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-analysis. Inflammopharmacology, 33(9), 5067–5083. https://doi.org/10.1007/s10787-025-01911-x

Downloads

Published

2026-09-24

How to Cite

Sobieraj, W., Sławatyniec, O., Pająk, J., Kamosińska, A., Łuniewska, W., Modrzyk, M., & Majda, A. (2026). NIGELLA SATIVA APPLICATIONS IN ALLERGIC DISEASE CONTROL: NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science, 4(3(51). https://doi.org/10.31435/ijitss.3(51).2026.6633

Most read articles by the same author(s)

<< < 1 2